Abstract
Mental disorders, such as major depressive disorder and schizophrenia, are complex multigenetic conditions, but focused studies of single genes might reveal genes involved in the pathogenesis of mental disorders, including major depressive disorder and schizophrenia. Several candidate genes have been identified using transgenic mice. VGF nerve growth factor inducible (VGF) is a neuropeptide expression of which is induced by nerve growth factor (NGF). VGF is robustly and exclusively synthesized in neuronal and neuroendocrine cells. In central nervous system (CNS), VGF is extensively expressed especially in the cerebral cortex, hippocampus, and hypothalamus. VGF has many roles in the CNS, such as promotion of synaptic plasticity, neurogenesis, and neurite outgrowth. In clinical studies, altered expression and genetic mutations of VGF have been reported in patients with major depressive disorder and schizophrenia. On this basis, studies using transgenic mice to overexpress or knockout VGF have been performed to investigate the roles of upregulation or downregulation of VGF. In this review, we will discuss studies of the roles of VGF using transgenic mice and its relevance to pathologies in major depressive disorder and schizophrenia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alder J, Thakker-Varia S, Bangasser DA, Kuroiwa M, Plummer MR, Shors TJ, Black IB (2003) Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J Neurosci 23(34):10800–10808
Allaman I, Fiumelli H, Magistretti PJ, Martin JL (2011) Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology 216(1):75–84. https://doi.org/10.1007/s00213-011-2190-y
Badescu SV, Tataru C, Kobylinska L, Georgescu EL, Zahiu DM, Zagrean AM, Zagrean L (2016) The association between diabetes mellitus and depression. J Med Life 9(2):120–125
Benson DL, Salton SR (1996) Expression and polarization of VGF in developing hippocampal neurons. Brain Res Dev Brain Res 96(1–2):219–228
Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311(5762):864–868. https://doi.org/10.1126/science.1120972
Bonni A, Ginty DD, Dudek H, Greenberg ME (1995) Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci 6(2):168–183. https://doi.org/10.1006/mcne.1995.1015
Bozdagi O, Rich E, Tronel S, Sadahiro M, Patterson K, Shapiro ML, Alberini CM, Huntley GW, Salton SR (2008) The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci 28(39):9857–9869. https://doi.org/10.1523/JNEUROSCI.3145-08.2008
Brigman JL, Wright T, Talani G, Prasad-Mulcare S, Jinde S, Seabold GK, Mathur P, Davis MI, Bock R, Gustin RM, Colbran RJ, Alvarez VA, Nakazawa K, Delpire E, Lovinger DM, Holmes A (2010) Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and cortex impairs long-term depression, reduces dendritic spine density, and disrupts learning. J Neurosci 30(13):4590–4600. https://doi.org/10.1523/JNEUROSCI.0640-10.2010
Busse S, Bernstein HG, Busse M, Bielau H, Brisch R, Mawrin C, Muller S, Sarnyai Z, Gos T, Bogerts B, Steiner J (2012) Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis. Eur Arch Psychiatry Clin Neurosci 262(5):365–374. https://doi.org/10.1007/s00406-011-0282-7
Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A, Gennarelli M (2010a) Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. Int J Neuropsychopharmacol 13(1):103–108. https://doi.org/10.1017/s1461145709990812
Cattaneo A, Sesta A, Calabrese F, Nielsen G, Riva MA, Gennarelli M (2010b) The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology 35(7):1423–1428. https://doi.org/10.1038/npp.2010.11
Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM (2013) Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline ‘predictors’ and longitudinal ‘targets’. Neuropsychopharmacology 38(3):377–385. https://doi.org/10.1038/npp.2012.191
Chen S, Jiang H, Hou Z, Yue Y, Zhang Y, Zhao F, Xu Z, Li Y, Mou X, Li L, Wang T, Zhao J, Han C, Sui Y, Wang M, Yang Z, Lu Y, Zhu Y, Li J, Shen X, Sun F, Chen Q, Yuan Y (2018) Higher serum VGF protein levels discriminate bipolar depression from major depressive disorder. J Neurosci Res. https://doi.org/10.1002/jnr.24377
Doherty JL, O’Donovan MC, Owen MJ (2012) Recent genomic advances in schizophrenia. Clin Genet 81(2):103–109. https://doi.org/10.1111/j.1399-0004.2011.01773.x
Ekelund J, Lichtermann D, Hovatta I, Ellonen P, Suvisaari J, Terwilliger JD, Juvonen H, Varilo T, Arajarvi R, Kokko-Sahin ML, Lonnqvist J, Peltonen L (2000) Genome-wide scan for schizophrenia in the Finnish population: evidence for a locus on chromosome 7q22. Hum Mol Genet 9(7):1049–1057
Ellis KL, Zhou Y, Rodriguez-Murillo L, Beshansky JR, Ainehsazan E, Selker HP, Huggins GS, Cupples LA, Peter I (2017) Common variants associated with changes in levels of circulating free fatty acids after administration of glucose-insulin-potassium (GIK) therapy in the IMMEDIATE trial. Pharmacogenomics J 17(1):76–83. https://doi.org/10.1038/tpj.2015.84
Ersland KM, Skrede S, Stansberg C, Steen VM (2017) Subchronic olanzapine exposure leads to increased expression of myelination-related genes in rat fronto-medial cortex. Transl Psychiatry 7(11):1262. https://doi.org/10.1038/s41398-017-0008-3
Fargali S, Garcia AL, Sadahiro M, Jiang C, Janssen WG, Lin WJ, Cogliani V, Elste A, Mortillo S, Cero C, Veitenheimer B, Graiani G, Pasinetti GM, Mahata SK, Osborn JW, Huntley GW, Phillips GR, Benson DL, Bartolomucci A, Salton SR (2015) Erratum. The granin VGF promotes genesis of secretory vesicles, and regulates circulating catecholamine levels and blood pressure. FASEB J 29(6):2679. https://doi.org/10.1096/fj.13-239509err
Ferri GL, Levi A, Possenti R (1992) A novel neuroendocrine gene product: selective VGF8a gene expression and immuno-localisation of the VGF protein in endocrine and neuronal populations. Brain Res Mol Brain Res 13(1–2):139–143
Ferri GL, Noli B, Brancia C, D’Amato F, Cocco C (2011) VGF: an inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. J Chem Neuroanat 42(4):249–261. https://doi.org/10.1016/j.jchemneu.2011.05.007
Hahm S, Mizuno TM, Wu TJ, Wisor JP, Priest CA, Kozak CA, Boozer CN, Peng B, McEvoy RC, Good P, Kelley KA, Takahashi JS, Pintar JE, Roberts JL, Mobbs CV, Salton SR (1999) Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance. Neuron 23(3):537–548
Heldt SA, Stanek L, Chhatwal JP, Ressler KJ (2007) Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories. Mol Psychiatry 12(7):656–670. https://doi.org/10.1038/sj.mp.4001957
Hoffman RP (2017) The complex inter-relationship between diabetes and schizophrenia. Curr Diabetes Rev 13(3):528–532. https://doi.org/10.2174/1573399812666161201205322
Hovatta I, Terwilliger JD, Lichtermann D, Makikyro T, Suvisaari J, Peltonen L, Lonnqvist J (1997) Schizophrenia in the genetic isolate of Finland. Am J Med Genet 74(4):353–360
Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S (2006) Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 3(11):e428. https://doi.org/10.1371/journal.pmed.0030428
Huang JT, Leweke FM, Tsang TM, Koethe D, Kranaster L, Gerth CW, Gross S, Schreiber D, Ruhrmann S, Schultze-Lutter F, Klosterkotter J, Holmes E, Bahn S (2007) CSF metabolic and proteomic profiles in patients prodromal for psychosis. PLoS ONE 2(8):e756. https://doi.org/10.1371/journal.pone.0000756
Hunsberger JG, Newton SS, Bennett AH, Duman CH, Russell DS, Salton SR, Duman RS (2007) Antidepressant actions of the exercise-regulated gene VGF. Nat Med 13(12):1476–1482. https://doi.org/10.1038/nm1669
Jiang H, Chen S, Lu N, Yue Y, Yin Y, Zhang Y, Jiang W, Liang J, Yuan Y (2017) Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients. World J Biol Psychiatry 18(8):586–591. https://doi.org/10.1080/15622975.2016.1224923
Jiang C, Lin WJ, Labonte B, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR (2018a) VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine. Neuropsychopharmacology. https://doi.org/10.1038/s41386-018-0277-4
Jiang C, Lin WJ, Sadahiro M, Labonte B, Menard C, Pfau ML, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR (2018b) VGF function in depression and antidepressant efficacy. Mol Psychiatry 23(7):1632–1642. https://doi.org/10.1038/mp.2017.233
Jiang C, Lin WJ, Salton SR (2018c) Role of a VGF/BDNF/TrkB autoregulatory feedback loop in rapid-acting antidepressant efficacy. J Mol Neurosci. https://doi.org/10.1007/s12031-018-1124-0
Kitaichi K, Yamada K, Hasegawa T, Furukawa H, Nabeshima T (1994) Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. Jpn J Pharmacol 66(2):181–189
Laslop A, Mahata SK, Wolkersdorfer M, Mahata M, Srivastava M, Seidah NG, Fischer-Colbrie R, Winkler H (1994) Large dense-core vesicles in rat adrenal after reserpine: levels of mRNAs of soluble and membrane-bound constituents in chromaffin and ganglion cells indicate a biosynthesis of vesicles with higher secretory quanta. J Neurochem 62(6):2448–2456
Levi A, Eldridge JD, Paterson BM (1985) Molecular cloning of a gene sequence regulated by nerve growth factor. Science 229(4711):393–395
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329(5994):959–964. https://doi.org/10.1126/science.1190287
Li C, Li M, Yu H, Shen X, Wang J, Sun X, Wang Q, Wang C (2017) Neuropeptide VGF C-terminal peptide TLQP-62 alleviates lipopolysaccharide-induced memory deficits and anxiety-like and depression-like behaviors in mice: the role of BDNF/TrkB signaling. ACS Chem Neurosci 8(9):2005–2018. https://doi.org/10.1021/acschemneuro.7b00154
Licht CM, de Geus EJ, Seldenrijk A, van Hout HP, Zitman FG, van Dyck R, Penninx BW (2009) Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 53(4):631–638. https://doi.org/10.1161/hypertensionaha.108.126698
Limandri BJ (2018) Ketamine for treatment-resistant depression: a gateway to novel treatment approaches. J Psychosoc Nurs Ment Health Serv 56(10):11–14. https://doi.org/10.3928/02793695-20180920-02
Lin P, Wang C, Xu B, Gao S, Guo J, Zhao X, Huang H, Zhang J, Chen X, Wang Q, Zhou W (2014) The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway. Pharmacol Biochem Behav 120:140–148. https://doi.org/10.1016/j.pbb.2014.03.003
Lin WJ, Jiang C, Sadahiro M, Bozdagi O, Vulchanova L, Alberini CM, Salton SR (2015) VGF and its C-terminal peptide TLQP-62 regulate memory formation in hippocampus via a BDNF-TrkB-dependent mechanism. J Neurosci 35(28):10343–10356. https://doi.org/10.1523/JNEUROSCI.0584-15.2015
Linn GS, Negi SS, Gerum SV, Javitt DC (2003) Reversal of phencyclidine-induced prepulse inhibition deficits by clozapine in monkeys. Psychopharmacology 169(3–4):234–239. https://doi.org/10.1007/s00213-003-1533-8
Lv D, Chen Y, Shen M, Liu X, Zhang Y, Xu J, Wang C (2018) Mechanisms underlying the rapid-acting antidepressant-like effects of neuropeptide VGF (non-acronymic) C-terminal peptide TLQP-62. Neuropharmacology 143:317–326. https://doi.org/10.1016/j.neuropharm.2018.09.046
Mizoguchi T, Minakuchi H, Ishisaka M, Tsuruma K, Shimazawa M, Hara H (2017) Behavioral abnormalities with disruption of brain structure in mice overexpressing VGF. Sci Rep 7(1):4691. https://doi.org/10.1038/s41598-017-04132-7
Mizoguchi T, Minakuchi H, Tanaka M, Tsuruma K, Shimazawa M, Hara H (2018) Sensorimotor gating deficits and effects of antipsychotics on the hyperactivity in VGF-overexpressing mice. Pharmacol Rep 70(3):476–480. https://doi.org/10.1016/j.pharep.2017.11.013
Mizoguchi T, Shimazawa M, Ohuchi K, Kuse Y, Nakamura S, Hara H (2019) Impaired cerebellar development in mice overexpressing VGF. Neurochem Res 44(2):374–387. https://doi.org/10.1007/s11064-018-2684-7
Morra LF, Strauss GP (2016) Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia. Schizophr Res 176(2–3):527–528. https://doi.org/10.1016/j.schres.2016.07.001
Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV (2013) Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry 74(4):250–256. https://doi.org/10.1016/j.biopsych.2012.06.022
Nicholls RE, Alarcon JM, Malleret G, Carroll RC, Grody M, Vronskaya S, Kandel ER (2008) Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility. Neuron 58(1):104–117. https://doi.org/10.1016/j.neuron.2008.01.039
Noda Y, Shimazawa M, Tanaka H, Tamura S, Inoue T, Tsuruma K, Hara H (2015) VGF and striatal cell damage in in vitro and in vivo models of Huntington’s disease. Pharmacol Res Perspect 3(3):e00140. https://doi.org/10.1002/prp2.140
Noda Y, Motoyama S, Nakamura S, Shimazawa M, Hara H (2019) Neuropeptide VGF-derived peptide LQEQ-19 has neuroprotective effects in an in vitro model of amyotrophic lateral sclerosis. Neurochem Res. https://doi.org/10.1007/s11064-019-02725-4
Noli B, Sanna F, Brancia C, D’Amato F, Manconi B, Vincenzoni F, Messana I, Melis MR, Argiolas A, Ferri GL, Cocco C (2017) Profiles of VGF peptides in the rat brain and their modulations after phencyclidine treatment. Front Cell Neurosci 11:158. https://doi.org/10.3389/fncel.2017.00158
Papaleo F, Silverman JL, Aney J, Tian Q, Barkan CL, Chadman KK, Crawley JN (2011) Working memory deficits, increased anxiety-like traits, and seizure susceptibility in BDNF overexpressing mice. Learn Mem 18(8):534–544. https://doi.org/10.1101/lm.2213711
Petrocchi-Passeri P, Cero C, Cutarelli A, Frank C, Severini C, Bartolomucci A, Possenti R (2015) The VGF-derived peptide TLQP-62 modulates insulin secretion and glucose homeostasis. J Mol Endocrinol 54(3):227–239. https://doi.org/10.1530/jme-14-0313
Possenti R, Eldridge JD, Paterson BM, Grasso A, Levi A (1989) A protein induced by NGF in PC12 cells is stored in secretory vesicles and released through the regulated pathway. EMBO J 8(8):2217–2223
Ramos A, Rodriguez-Seoane C, Rosa I, Trossbach SV, Ortega-Alonso A, Tomppo L, Ekelund J, Veijola J, Jarvelin MR, Alonso J, Veiga S, Sawa A, Hennah W, Garcia A, Korth C, Requena JR (2014) Neuropeptide precursor VGF is genetically associated with social anhedonia and underrepresented in the brain of major mental illness: its downregulation by DISC1. Hum Mol Genet 23(22):5859–5865. https://doi.org/10.1093/hmg/ddu303
Rodriguez-Santiago B, Brunet A, Sobrino B, Serra-Juhe C, Flores R, Armengol L, Vilella E, Gabau E, Guitart M, Guillamat R, Martorell L, Valero J, Gutierrez-Zotes A, Labad A, Carracedo A, Estivill X, Perez-Jurado LA (2010) Association of common copy number variants at the glutathione S-transferase genes and rare novel genomic changes with schizophrenia. Mol Psychiatry 15(10):1023–1033. https://doi.org/10.1038/mp.2009.53
Salton SR, Fischberg DJ, Dong KW (1991) Structure of the gene encoding VGF, a nervous system-specific mRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells. Mol Cell Biol 11(5):2335–2349
Sams-Dodd F (1995) Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment. J Neurosci Methods 59(2):157–167
Serafini G, Howland RH, Rovedi F, Girardi P, Amore M (2014) The role of ketamine in treatment-resistant depression: a systematic review. Curr Neuropharmacol 12(5):444–461. https://doi.org/10.2174/1570159X12666140619204251
Severini C, Ciotti MT, Biondini L, Quaresima S, Rinaldi AM, Levi A, Frank C, Possenti R (2008) TLQP-21, a neuroendocrine VGF-derived peptide, prevents cerebellar granule cells death induced by serum and potassium deprivation. J Neurochem 104(2):534–544. https://doi.org/10.1111/j.1471-4159.2007.05068.x
Shen M, Lv D, Liu X, Li S, Chen Y, Zhang Y, Wang Z, Wang C (2018) Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice. Brain Res Bull 143:58–65. https://doi.org/10.1016/j.brainresbull.2018.10.004
Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22(8):3251–3261
Snyder SE, Salton SR (1998) Expression of VGF mRNA in the adult rat central nervous system. J Comp Neurol 394(1):91–105
Snyder SE, Cheng HW, Murray KD, Isackson PJ, McNeill TH, Salton SR (1998) The messenger RNA encoding VGF, a neuronal peptide precursor, is rapidly regulated in the rat central nervous system by neuronal activity, seizure and lesion. Neuroscience 82(1):7–19
Stephens SB, Schisler JC, Hohmeier HE, An J, Sun AY, Pitt GS, Newgard CB (2012) A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet beta-cell survival and function. Cell Metab 16(1):33–43. https://doi.org/10.1016/j.cmet.2012.05.011
Stephens SB, Edwards RJ, Sadahiro M, Lin WJ, Jiang C, Salton SR, Newgard CB (2017) The prohormone VGF regulates beta cell function via insulin secretory granule biogenesis. Cell Rep 20(10):2480–2489. https://doi.org/10.1016/j.celrep.2017.08.050
Takeuchi H, Inagaki S, Morozumi W, Nakano Y, Inoue Y, Kuse Y, Mizoguchi T, Nakamura S, Funato M, Kaneko H, Hara H, Shimazawa M (2018) VGF nerve growth factor inducible is involved in retinal ganglion cells death induced by optic nerve crush. Sci Rep 8(1):16443. https://doi.org/10.1038/s41598-018-34585-3
Thakker-Varia S, Krol JJ, Nettleton J, Bilimoria PM, Bangasser DA, Shors TJ, Black IB, Alder J (2007) The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 27(45):12156–12167. https://doi.org/10.1523/JNEUROSCI.1898-07.2007
Thakker-Varia S, Jean YY, Parikh P, Sizer CF, Jernstedt Ayer J, Parikh A, Hyde TM, Buyske S, Alder J (2010) The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithium. J Neurosci 30(28):9368–9380. https://doi.org/10.1523/JNEUROSCI.5987-09.2010
van den Pol AN, Bina K, Decavel C, Ghosh P (1994) VGF expression in the brain. J Comp Neurol 347(3):455–469. https://doi.org/10.1002/cne.903470311
Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J (2008) Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 320(5875):539–543. https://doi.org/10.1126/science.1155174
Wedenoja J, Loukola A, Tuulio-Henriksson A, Paunio T, Ekelund J, Silander K, Varilo T, Heikkila K, Suvisaari J, Partonen T, Lonnqvist J, Peltonen L (2008) Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol Psychiatry 13(7):673–684. https://doi.org/10.1038/sj.mp.4002047
Yamaguchi H, Sasaki K, Satomi Y, Shimbara T, Kageyama H, Mondal MS, Toshinai K, Date Y, Gonzalez LJ, Shioda S, Takao T, Nakazato M, Minamino N (2007) Peptidomic identification and biological validation of neuroendocrine regulatory peptide-1 and -2. J Biol Chem 282(36):26354–26360. https://doi.org/10.1074/jbc.M701665200
Yang C, Shirayama Y, Zhang JC, Ren Q, Yao W, Ma M, Dong C, Hashimoto K (2015) R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry 5:e632. https://doi.org/10.1038/tp.2015.136
Zamanillo D, Sprengel R, Hvalby O, Jensen V, Burnashev N, Rozov A, Kaiser KM, Koster HJ, Borchardt T, Worley P, Lubke J, Frotscher M, Kelly PH, Sommer B, Andersen P, Seeburg PH, Sakmann B (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284(5421):1805–1811
Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate CA Jr, Gould TD (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533(7604):481–486. https://doi.org/10.1038/nature17998
Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856–864. https://doi.org/10.1001/archpsyc.63.8.856
Zeng H, Chattarji S, Barbarosie M, Rondi-Reig L, Philpot BD, Miyakawa T, Bear MF, Tonegawa S (2001) Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell 107(5):617–629
Author information
Authors and Affiliations
Contributions
TM, MS, and HH wrote the paper. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Mizoguchi, T., Hara, H. & Shimazawa, M. VGF has Roles in the Pathogenesis of Major Depressive Disorder and Schizophrenia: Evidence from Transgenic Mouse Models. Cell Mol Neurobiol 39, 721–727 (2019). https://doi.org/10.1007/s10571-019-00681-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-019-00681-9